Meet the Precision
AQ team at
MAPS Americas 2026
Denver, CO | March 22-25, 2026
Precision AQ is a commercialization partner for biopharma innovators, market access teams, and brand strategists. Working with clients from all 30 of the world’s top pharma companies, we specialize in turning data chaos into commercial clarity.
Our proprietary Access Made Possible technology integrates payer, provider, and patient insights to deliver scalable, actionable strategies that widen access to innovation. At Precision AQ, we believe access is earned with evidence, empathy, and precision.
Innovation alone doesn’t change lives — the story it inspires does. We dig deep to translate the science behind novel therapies into insight-driven communications that educate, inspire, and activate health care professionals across every stage of commercialization. From advisory board meetings and expert engagements to publications and promotional medical education, we bring data to life, always grounded in a deep understanding of the science, our client’s objectives, and a commitment to flawless execution.
By combining our scientific acumen and strategic expertise with Key Opinion Leader (KOL) insights and our content development prowess, we bring your scientific story to life to empower access to life-changing medicines for all.
Our data-driven approach provides the insights and engagement you need to reach and activate all key stakeholders.
Complete the form to book a meeting, and we’ll reach out to confirm the details.
Greg Gregory, PhD | Executive Vice President, Partner, Precision AQ Hannah Deresiewicz | EVP, Managing Director,...
Stephanie Spence, PharmD, CSP, Senior Director, Access Experience Team
Christopher Terrone | VP, Healthcare Insights Cynthia Miller, MD, MPH, FACP | VP, Medical Director, Access Experience...